|- Annual course aims to boost nations’ capacity to tackle infectious diseases
Seoul, KOREA - The International Vaccine Institute (IVI) will kick-off ´the Ninth International Advanced Course on Vaccinology for the Asia Pacific Regions´ on May 11. The week-long training course for professionals is designed to help countries boost their capacity in the area of vaccine evaluation, introduction and policy through training of professionals in the region.
|Dr. Michael Favorov, IVI’s Deputy Director-General for Translational Research, delivers opening remarks at the ‘Ninth International Advanced Course on Vaccinology for the Asia Pacific Regions’ on May 11, 2009.
The annual event will bring together over 100 participants, including faculty, from 25 countries. The participants include scientists, public health officials and policymakers involved in vaccine development and vaccination policies, both from the private and public sectors.
More than 20 experts from the IVI, universities, research institutions, industry, non-profit organizations, and international agencies (including the World Health Organization and the Bill and Melinda Gates Foundation) will serve as faculty for the course. Prof. Ian Gust, a leading virologist and vaccine expert from the University of Melbourne, will make a keynote speech on May 15 entitled, "The Future of vaccines and vaccination with special emphasis on influenza and other pandemics." He will present an overview of the history of vaccines and recent trends in vaccinology, and focus on the need to address the gap between developed and developing countries in immunization coverage and the availability and use of new-generation vaccines.
The course aims to help countries, especially in the developing world, better cope with the threat of infectious diseases, including emerging diseases such as influenza A (H1N1), by expanding their understanding of key issues related to vaccine development, production, evaluation and introduction. Fifteen professionals from developing countries are attending the course free of charge through a fellowship.
The participants will discuss the entire vaccine continuum, from discovery in the laboratory to vaccine evaluation, licensure and regulatory issues, production, introduction strategies and financing mechanisms. The course covers a range of disciplines, including the basics of epidemiology and immunology, the latest in vaccine technology and delivery systems, vaccine economics and financing, and ethical issues related to field testing and delivery of vaccines. It also covers a range of infectious diseases and vaccines, including those against enteric diseases (rotavirus, cholera, and typhoid fever), respiratory diseases such as influenza and Haemophilus influenzae type b (Hib), Flaviviruses such as Japanese encephalitis and dengue fever, malaria and human papillomavirus (HPV).
The course comprises lectures, case studies, and roundtable discussions designed to encourage interaction between participants and faculty. Topics for discussion include “vaccine delivery systems,” "technology transfer," and "the changing regulatory environment."
The event is hosted by the IVI, and sponsored by the Ministry of Education, Science and Technology of Korea, Swedish International Development Cooperation Agency (SIDA), GlaxoSmithKline Biologicals, the Bill & Melinda Gates Foundation, and the Korea Exchange Bank Foundation.
The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Established as an initiative of the United Nations Development Program in 1997, the IVI operates under a treaty signed by 40 countries and the World Health Organization. The Institute conducts research in 28 countries of Asia, Africa and Latin America on vaccines against diarrheal infections, bacterial meningitis and pneumonia, as well as Japanese encephalitis and dengue fever, and develops new and improved vaccines at its headquarters in Seoul. For more information, please visit www.ivi.int